A detailed history of Scharf Investments, LLC transactions in Novartis Ag stock. As of the latest transaction made, Scharf Investments, LLC holds 1,277,793 shares of NVS stock, worth $124 Million. This represents 4.52% of its overall portfolio holdings.

Number of Shares
1,277,793
Previous 1,351,452 5.45%
Holding current value
$124 Million
Previous $144 Million 2.15%
% of portfolio
4.52%
Previous 4.48%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$106.13 - $120.89 $7.82 Million - $8.9 Million
-73,659 Reduced 5.45%
1,277,793 $147 Million
Q2 2024

Jul 23, 2024

SELL
$92.57 - $107.37 $1.24 Million - $1.44 Million
-13,402 Reduced 0.98%
1,351,452 $144 Million
Q1 2024

Apr 15, 2024

SELL
$95.27 - $108.47 $5.61 Million - $6.39 Million
-58,866 Reduced 4.13%
1,364,854 $132 Million
Q4 2023

Jan 12, 2024

SELL
$92.27 - $101.54 $186,846 - $205,618
-2,025 Reduced 0.14%
1,423,720 $144 Million
Q3 2023

Oct 13, 2023

SELL
$94.73 - $105.13 $7.14 Million - $7.92 Million
-75,341 Reduced 5.02%
1,425,745 $145 Million
Q2 2023

Jul 24, 2023

SELL
$92.52 - $104.91 $11.6 Million - $13.1 Million
-124,889 Reduced 7.68%
1,501,086 $151 Million
Q1 2023

Apr 14, 2023

BUY
$80.03 - $92.81 $4.06 Million - $4.7 Million
50,682 Added 3.22%
1,625,975 $150 Million
Q4 2022

Feb 03, 2023

BUY
$75.55 - $92.52 $12.1 Million - $14.8 Million
159,673 Added 11.28%
1,575,293 $143 Million
Q3 2022

Oct 25, 2022

BUY
$74.61 - $87.26 $6.94 Million - $8.12 Million
93,014 Added 7.03%
1,415,620 $108 Million
Q2 2022

Jul 19, 2022

SELL
$80.52 - $93.75 $1.46 Million - $1.69 Million
-18,074 Reduced 1.35%
1,322,606 $112 Million
Q1 2022

Apr 13, 2022

BUY
$80.11 - $90.62 $6.3 Million - $7.12 Million
78,603 Added 6.23%
1,340,680 $118 Million
Q4 2021

Jan 20, 2022

BUY
$79.7 - $88.13 $1.38 Million - $1.53 Million
17,366 Added 1.4%
1,262,077 $110 Million
Q3 2021

Oct 14, 2021

SELL
$81.78 - $95.14 $1.46 Million - $1.7 Million
-17,882 Reduced 1.42%
1,244,711 $102 Million
Q2 2021

Jul 16, 2021

BUY
$85.24 - $94.15 $4.93 Million - $5.45 Million
57,893 Added 4.81%
1,262,593 $115 Million
Q1 2021

Apr 14, 2021

BUY
$83.5 - $98.47 $597,943 - $705,143
7,161 Added 0.6%
1,204,700 $103 Million
Q4 2020

Jan 20, 2021

SELL
$78.07 - $94.43 $1.16 Million - $1.4 Million
-14,815 Reduced 1.22%
1,197,539 $113 Million
Q3 2020

Oct 19, 2020

SELL
$82.14 - $91.0 $7.43 Million - $8.24 Million
-90,508 Reduced 6.95%
1,212,354 $105 Million
Q2 2020

Jul 16, 2020

SELL
$80.93 - $91.1 $2.21 Million - $2.49 Million
-27,313 Reduced 2.05%
1,302,862 $114 Million
Q1 2020

May 05, 2020

BUY
$70.67 - $99.01 $13.3 Million - $18.6 Million
188,354 Added 16.5%
1,330,175 $110 Million
Q4 2019

Feb 13, 2020

SELL
$84.35 - $95.37 $3.05 Million - $3.44 Million
-36,118 Reduced 3.07%
1,141,821 $108 Million
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $8.61 Million - $9.48 Million
-100,618 Reduced 7.87%
1,177,939 $102 Million
Q2 2019

Aug 13, 2019

BUY
$75.4 - $92.8 $30.6 Million - $37.6 Million
405,449 Added 46.44%
1,278,557 $117 Million
Q1 2019

May 14, 2019

SELL
$75.32 - $86.15 $1.65 Million - $1.89 Million
-21,894 Reduced 2.45%
873,108 $83.9 Million
Q4 2018

Feb 13, 2019

BUY
$73.66 - $82.02 $6.41 Million - $7.13 Million
86,972 Added 10.76%
895,002 $76.8 Million
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $2.32 Million - $2.69 Million
34,708 Added 4.49%
808,030 $69.6 Million
Q2 2018

Aug 13, 2018

SELL
$64.91 - $73.36 $1.73 Million - $1.96 Million
-26,660 Reduced 3.33%
773,322 $58.4 Million
Q1 2018

May 14, 2018

SELL
$70.39 - $84.15 $6.17 Million - $7.38 Million
-87,683 Reduced 9.88%
799,982 $64.7 Million
Q4 2017

Feb 14, 2018

SELL
$72.33 - $77.64 $3.75 Million - $4.03 Million
-51,887 Reduced 5.52%
887,665 $74.5 Million
Q3 2017

Nov 14, 2017

SELL
$74.14 - $77.27 $1.73 Million - $1.8 Million
-23,275 Reduced 2.42%
939,552 $80.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
962,827
962,827 $80.4 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Scharf Investments, LLC Portfolio

Follow Scharf Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scharf Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scharf Investments, LLC with notifications on news.